Lilly Pulitzer's Aria shift dress flaunts a classic split V-neck with contrast trim and bow accents. Split V-neck Sleeveless Back zip closure 98% cotton/2% spandex Dry clean Imported SIZE & FIT Model ...

Lilly Pulitzer is serving up a Valentine's Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking their second collaboration, "Lilly Loves Lele" is a six-piece limited ...

President Donald Trump scored a significant legal win Monday in his lawsuit against the members of the Pulitzer Prize Board, paving the way towards the discovery phase in their courtroom battle.

Pulitzer Prize-winning cartoonist Darrin Bell has been arrested on suspicion of possessing child sexual abuse videos, including AI-generated material. The Sacramento County Sheriff's Office said ...

On the topic of manufacturing, Lilly has spent the past few years laying out billions of dollars to grow production capacity for Mounjaro and Zepbound. Despite the formal conclusion of Lilly’s ...

A Trump-bashing, Pulitzer Prize-winning political cartoonist — whose illustrations have been published by the Washington Post, New Yorker and Los Angeles Times — was arrested for possession of ...

Bell’s career as a cartoonist spans decades, earning him significant accolades, including the 2019 Pulitzer Prize for editorial cartoons. His award-winning work, praised for tackling issues such ...

Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss ...

Pulitzer Prize-winning cartoonist Darrin Lawrence Bell is facing felony child pornography charges over a trove of graphic videos — some of them AI-generated — that detectives say the 49-year ...

In this article, we are going to take a look at where Eli Lilly And Co. (NYSE:LLY) stands against other stocks that could split in the near future. Stock splits don’t change how much a company ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...